ArticleBiomedical reports2024

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.

Nan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.